Free Trial

Skandinaviska Enskilda Banken AB publ Decreases Stake in Doximity, Inc. (NASDAQ:DOCS)

Doximity logo with Medical background
Remove Ads

Skandinaviska Enskilda Banken AB publ reduced its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 9.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 878,700 shares of the company's stock after selling 95,000 shares during the quarter. Skandinaviska Enskilda Banken AB publ owned 0.47% of Doximity worth $46,975,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the company. Global Retirement Partners LLC increased its holdings in shares of Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after acquiring an additional 440 shares during the period. UMB Bank n.a. raised its stake in shares of Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after buying an additional 235 shares in the last quarter. Farther Finance Advisors LLC lifted its holdings in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock valued at $34,000 after acquiring an additional 603 shares during the last quarter. Larson Financial Group LLC boosted its holdings in Doximity by 49.4% during the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after buying an additional 250 shares in the last quarter. Finally, Morse Asset Management Inc acquired a new position in shares of Doximity in the 3rd quarter worth $46,000. 87.19% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have weighed in on DOCS. Piper Sandler upgraded shares of Doximity from a "neutral" rating to an "overweight" rating and upped their price objective for the company from $31.00 to $78.00 in a research note on Friday, February 7th. Mizuho lifted their target price on shares of Doximity from $55.00 to $65.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. JPMorgan Chase & Co. raised their price objective on shares of Doximity from $30.00 to $48.00 and gave the stock a "neutral" rating in a research note on Thursday, November 21st. KeyCorp cut their price target on Doximity from $70.00 to $65.00 and set an "overweight" rating for the company in a report on Wednesday, January 8th. Finally, Bank of America lifted their target price on shares of Doximity from $54.00 to $57.00 and gave the company a "neutral" rating in a research report on Monday, January 6th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $64.22.

Remove Ads

Get Our Latest Research Report on Doximity

Doximity Stock Down 1.5 %

DOCS stock traded down $0.98 during midday trading on Monday, hitting $62.40. The company's stock had a trading volume of 2,447,781 shares, compared to its average volume of 1,860,903. The firm has a market capitalization of $11.65 billion, a price-to-earnings ratio of 62.40, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21. The company has a 50 day moving average of $63.63 and a two-hundred day moving average of $52.72.

Insider Transactions at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now owns 6,360 shares of the company's stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 37.40% of the company's stock.

About Doximity

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Featured Stories

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads